Triplex Pharmaceutical Corp., Zynaxis deal

The companies will develop ZNXS's Zyn-Linker drug delivery molecules with certain Triplex oligonucleotides. Zyn-Linkers are synthetic lipid-like molecules that insert into cell membranes. Triplex (The...